Codexis eyes biofuel technology license from Shell
US-based biofuels production process developer Codexis has signed an exclusive negotiation agreement with Shell, the company announced on Monday.
Under the agreement, Shell has agreed to negotiate exclusively with Codexis through September 1 on the terms of a new agreement under which Shell would grant certain rights and licenses in the biofuels field to develop and sell cellulase enzymes to third parties on a worldwide basis, except Brazil.
Codexis has exclusive rights to commercialize its cellulase enzyme technology in all other fields, it said.
“Currently, Codexis’ cellulase enzyme technology can only be commercialized in the advanced biofuels field through Shell and its affiliates,” said John Nicols, Codexis CEO.
“If we finalize a new agreement with Shell as we currently anticipate, the rest of the world’s second-generation biofuels producers will now also be available as target customers for our cost effective cellulase enzyme technology.”
Related News
- Climate Investment leads $27-MM Series B investment in Membrane Technology and Research (MTR) to scale its use in industrial applications
- Trump's shipping waiver does not boost oil flows within U.S.; fuel exports soar
- EIB and Eni sign €500-MM in financing for new biorefinery in Sannazzaro de’ Burgondi
Comments